InforMax Reaches 10,000 User Mark for Bioinformatics Software

<%=company1%> (Rockville, MD) announced that recent global and multi-site licenses of Vector NTI Suite by major pharmaceutical and agricultural companies have propelled InforMax past the 10,000 user mark for their industry-leading software. Vector NTI Suite is the most comprehensive desktop software suite available for integrated DNA and Protein Sequence Analysis.

"Reaching the 10,000 user mark is tremendous validation of our capabilities," said Dr. Alex Titomirov, founder and CEO. "The marketplace is the ultimate judge of whether one's company is on the right track. Over 60 pharmaceutical companies, 250 biotechnology firms, and 400 universities have purchased our products. Now, we intend to expand our customer relationships that we have built through Vector NTI Suite into comprehensive relationships focused on the problem of increasing overall R&D productivity. We will enable major process change using our enterprise product Software Solution for BioMedicine (SSBM)."

"I chose InforMax because of their clear leadership in providing tools that enhance the productivity of the bench scientist," said Frank White, Bioinformatics Scientist, Berlex Biosciences (Richmond, CA). "I see the same development advantage in their enterprise product, SSBM."

About InforMax Inc.
Headquartered in Rockville, MD, InforMax is a leader in the development of bioinformatics software for accelerated drug discovery. InforMax, founded in 1990 by Dr. Alex Titomirov, enables over 10,000 researchers worldwide to achieve greater insights into genetic function through biological data mining and integrated sequence analysis. Unlike other bioinformatics software, InforMax products are designed with the ResearchLogic system, a knowledge base that mirrors the molecular biologist's natural process of scientific inquiry. Presently, InforMax offers Vector NTI Suite for desktop sequence analysis and Software Solution for BioMedicine for enterprise bioinformatics.